secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioNexus Gene Lab Corp (BGLC)
CIK:        0001737523
Form:       8-K
Filed at:   2025-12-30T23:59:59+00:00
Accession:  0001477932-25-009240
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BioNexus Gene Lab Corp. shareholders elect all four director nominees and approve 2025 equity plan
--------------------------------------------------------------------------------

- Directors re-elected: Su-Leng Tan Lee, Muhammad Azrul bin Abdul Hamid, Jook Yuen Low, Chee Keong Yap.
- 2025 Equity Incentive Plan approved with 966,759.8 votes for, 10,628.5 against.
- JP Centurion & Partners PLT ratified as independent auditor for FY 2025.
- Adjournment proposal approved if needed to solicit additional proxies.
- All proposals passed; meeting held December 24, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737523/000147793225009240/0001477932-25-009240-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737523/000147793225009240/bglc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-009240

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer